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A newly discovered family of proteins homologous to
yeast Cdc53, called cullins, may play a key role in the
targeting of cell-cycle regulators, such as cyclins, for
destruction by ubiquitin-dependent proteolysis.
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The covalent addition of ubiquitin to proteins directs their
degradation by the proteasome [1]. Ubiquitination
enzymes promote the destruction of misfolded, damaged
or constitutively unstable proteins. Furthermore, the ubiq-
uitination of specific targets has been shown to be critical
for controlling cell-cycle progression and sensing cellular
damage. The diversity of potential ubiquitination targets
and the large family of ubiquitination enzymes raises the
question of how specific proteins are targeted for ubiquiti-
nation. Recent studies have suggested that the yeast
Cdc53 protein specifically associates with the phosphory-
lated form of a cyclin that is ubiquitinated at a specific
stage of the cell cycle [2]. A family of proteins, called
‘cullins’, that are homologous to Cdc53 has been discov-
ered. Cullins may bind to distinct target proteins, provid-
ing one explanation for how the ubiquitination system
discriminates among its substrates and how phosphoryla-
tion may be used as a regulatory signal for initiating
protein destruction.
The ubiquitin-dependent proteolysis machinery
Protein degradation by the ubiquitin pathway requires
distinct enzymatic steps (Fig. 1). In the first step, a ubiq-
uitin-activating enzyme (E1) uses ATP to form a thioles-
ter bond between itself and ubiquitin. This activated
ubiquitin is then transferred to one of a family of ubiqui-
tin-conjugating enzymes (E2s). Some E2s directly cat-
alyze formation of an isopeptide bond between the
carboxyl terminus of ubiquitin and the e-amino group of
an internal lysine residue in a substrate protein; others
require a ubiquitin ligase (E3) to transfer ubiquitin from
the E2 to the substrate. The E2s provide substantial sub-
strate specificity to the ubiquitination reaction [3]. It is not
clear whether E3s form a single family of enzymes, nor do
we understand their biochemical action in all cases. Some
E3s form a ubiquitin–thiolester linkage; others may
directly couple E2s to the substrate molecule. The latter
role has been suggested for the ‘anaphase promoting
complex’ (APC), a multiprotein complex critical for the
destruction of cyclin B in mitosis [4,5].
Within a given protein substrate, a small number of
lysines are typically used for ubiquitination. Monoubiqui-
tination is not sufficient, however, to target a protein for
destruction — long polyubiquitin chains must be formed
to direct substrates to the proteasome for degradation in
vivo. Polyubiquitination may involve distinct E2s or
E2/E3 combinations and more than one kind of ubiqui-
tin–ubiquitin linkage in any chain [1]. The dynamics and
regulation of chain formation are not well understood.
Opposing the action of the ubiquitinating enzymes are a
large group of de-ubiquitinating enzymes or isopeptidases
[1]. Deubiquitination may ensure fidelity or cooperativity
in the ubiquitination process, thereby avoiding spurious
protein destruction. De-ubiquitinating enzymes may also
be important for recycling ubiquitin after proteasome-
mediated destruction of a specific protein [1].
Signal sequences and regulation by phosphorylation
The discovery that cyclin B undergoes rapid, ubiquitin-
dependent destruction in mitosis explained why cyclin B
oscillates in abundance every cell-cycle [6]. A cyclin B
sequence required for its mitotic destruction, the ‘destruc-
tion box’, was identified and turns up in other mitotically
destroyed proteins. Degradation of cyclin B via the
destruction box appears to be regulated at the level of the
mitotic destruction machinery: the APC appears to be acti-
vated in mitosis [4,5,7], presumably by phosphorylation,
although the detailed mechanism is not known.
Another important type of degradation signal is the
‘PEST’ sequence, the acronym being the single-letter
code for the amino acids abundant in such sequences.
PEST sequences are found in unstable proteins, includ-
ing the yeast cyclins Cln2 and Cln3 [3]. Although muta-
tions in PEST sequences show that they confer
instability, they are neither essential nor sufficient for tar-
geting proteins for destruction [8]. Phosphorylation is a
critical modification for degradation of the PEST-contain-
ing cyclin Cln2. Phosphorylation of Cln2 occurs upon
binding to its associated Cdc28 protein kinase (the
budding yeast Cdc2 homologue) and requires Cdc28
kinase activity [9]. Mutagenesis experiments showed that
phosphorylation of Cln2, presumably by Cdc28, is
required for its instability, providing a self-limiting activa-
tion of Cdc28 by Cln2. Although a highly stabilized,
mutant form of Cln2 that lacks the phosphorylation sites
can rescue viability, it accelerates progression though G1
and makes yeast resistant to growth arrest in response to
nutrient starvation or pheromone. Cyclin instability thus
appears to be critical for setting the rate of G1 progression
in response to extracellular cues.
Control of G1 progression by Cdc34, Cdc4 and Cdc53
Ubiquitin-dependent proteolysis was shown to have an
important physiological role when a protein critical for G1
progression, Cdc34, was found to be homologous to E2s
[10]. Genetic analysis showed that Cdc34, Cdc4 and
Cdc53 are critical for a step in G1 progression after
‘START’ — the key point when a budding yeast commits
to cell division — but before the initiation of DNA repli-
cation. Genetic interactions further suggested that these
three proteins might function in a common pathway and
physically interact [3]. It has recently been confirmed that
Cdc53 can bind both Cdc34 and Cdc4, and one or several
Cdc53-containing complexes may exist in the cell [2].
A central role for Cdc34 in G1 was recently demonstrated
by Nasmyth and coworkers [11], who showed that it is
required for the degradation of Sic1, an inhibitor of cyclin-
dependent kinases (Cdks). Although not required for via-
bility, Sic1 accumulates late in mitosis and throughout G1,
and is degraded after START. Sic1 restrains S-phase entry
by binding to the cyclin–Cdk complex Clb5–Cdc28,
which accelerates passage through S phase. In cdc34ts,
cdc4ts or cdc53ts mutants, Sic1 accumulates and cells fail to
enter S phase (Fig. 1). Dramatically, deletion of SIC1
removed the block to S-phase entry in cdc34ts, cdc4ts or
cdc53ts mutants, so Sic1 appears to be the critical target for
the Cdc34 pathway in controlling the G1–S transition.
The SIC1 deletion did not, however, rescue the ability of
these mutant strains to divide, suggesting that there must
be other critical substrates for the Cdc34 pathway.
That yeast cyclins Cln1, Cln2 and Cln3 are required for
G1 progression suggested that their stability may deter-
mine the rate of G1 progression. This view is supported
by biochemical and genetic evidence that the Cdc34
pathway is required for Cln destruction in vitro and in vivo
[8,12], and by the finding that yeast expressing a stabilized
Cln fail to respond to nutritional or pheromone arrest [9].
In addition to Cdc53 and Cdc34, a protein with homology
to Cdc4, called Grr1, may be important for determining
Cln2 stability [13].
Cdc34 also appears to be required for instability of the
transcription factor Gcn4, which induces transcription of
genes required for amino-acid biosynthesis [14]. Under
nutritional starvation, Gcn4 is stabilized, promoting tran-
scription of genes encoding amino-acid biosynthesis
enzymes. When yeast cells are provided with amino acids
in rich media, Gcn4 is targeted for ubiquitination via its
PEST sequences. In cdc34 mutants, Gcn4 is stabilized,
suggesting that Cdc34 is required for Gcn4 instability. It is
possible that the Cdc34 pathway may itself be modulated
by nutritional status, possibly mediating a checkpoint
control [3]. The human homologue of Cdc34 is capable of
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Multiple Cdc34/Cdc53 complexes regulate destruction of cyclins and Cdk inhibitors. See text for details.
causing ubiquitination of p27, an inhibitor of the cyclin
E–Cdk2 kinase [15]; cyclin E is required for S-phase entry
and its inhibitor p27 appears to be activated by transform-
ing growth factor-b (TGF-b). Cdc34 may thus mediate
growth factor signaling in multicellular eukaryotes.
A solution to the recognition problem for ubiquitination
substrates was recently suggested by Tyers and colleagues
[2], who observed that Cdc53 binds specifically to phos-
phorylated Cln2, but not to unphosphorylated Cln2 or B-
type cyclins. Clns are unstable when phosphorylated, and
measurements of Cln stability in cdc53 or cdc34 mutant
strains confirmed that Cdc53 is required for Cln instabil-
ity. Tyers’ group [2] additionally showed that Cdc53 is
itself ubiquitinated and interacts directly with Cdc34. As
Cdc53 interacts with both the substrate protein (Cln) and
with the apparent E2 (Cdc34), they argue that Cdc53 is
part of an E3. Although Cdc53 may direct the specific
interaction of phosphorylated species, the interaction
between Cdc53 and phosphorylated substrate was not
shown to be direct. Other proteins, including Cdc4 or
Grr1, may provide a bridge between Cdc53, Cdc34 and
phosphorylated substrate (Fig. 1).
Skp1, Sic1 destruction and the F box
Two novel ‘S-phase kinase-associated’ proteins, Skp1 and
Skp2, were recently discovered in association with cyclin
A–Cdk2 complexes [16]. Anti-Skp2 antibodies blocked S-
phase entry, suggesting that Skp2 has a direct role in DNA
replication control. Genetic experiments pointed to a
direct interaction between Skp1 and Cdc4, explained by
the discovery that Skp1 binds to a structural motif within
Cdc4, called the F box (Fig. 2) [17]. F boxes are found in
many proteins, including cyclin F and Skp2, explaining
Skp1’s association with these proteins. Skp1 was found to
be required for the G1–S and G2–M transitions [17]. Sic1
and Cln2 are stabilized in skp1 mutants, suggesting that
Skp1 may act, in concert with Cdc34, Cdc4 and Cdc53, to
promote the degradation of specific substrates required for
the G1–S (Fig. 1) and G2–M transitions.
A different possible function for Skp1 was suggested by
the finding that Skp1 associates with the yeast kinetochore
complex, CBF3 [18]. CBF3 is a complex of three proteins,
p110, p64 and p58, which bind to a defined site, CDEIII, in
centromere DNA. Mutations in these kinetochore compo-
nents cause chromosome missegregation and loss of viabil-
ity. To find gene products that interact with CBF3, Hieter
and coworkers [18] screened for high-copy suppressors of
mutations in the p58 gene, CTF13. The suppressors
occurred in either CTF13 itself or in SKP1. Skp1 was subse-
quently shown to be part of the CBF3–CDEIII complex,
and skp1 mutants were found to exhibit chromosome mis-
segregation and cell-cycle arrest with a short mitotic
spindle, indicating a pre-anaphase block. Reconstitution of
the CBF3 complex also demonstrated that Skp1 is required
for formation of a CBF3–centromere complex [19].
There are several potential explanations for Skp1’s multi-
ple roles in G1 progression and kinetochore function. One
is that Skp1 is primarily involved in kinetochore function,
and skp1 deficiencies induce a checkpoint control that
causes a G1 block, stabilizing Sic1. A more interesting pos-
sibility is that Skp1 plays multiple roles: at the kineto-
chore through binding CBF3, at an undefined replication
structure by binding Skp2 and the cyclin A–Cdk2
complex, and in the destruction of Sic1. Skp1’s role in pro-
moting protein destruction may be to recruit ubiquitina-
tion enzymes or the proteasome to specific targets. Bai et
al. [17] suggested Skp1 might recruit the APC, an E3, to
the kinetochore to promote destruction of proteins that
maintain the cohesion of sister chromatids.
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Figure 2
Skp1 associates with multiple F-box-
containing proteins and cullins to produce
diverse complexes. Several of the F-box-
containing proteins themselves contain
sequences thought to mediate
protein–protein interactions, including 
WD-40 and leucine-rich repeats and the
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Skp1 may bind via F-box interactions to Cdc4, Skp2 and
Grr1, which may in turn bind to substrate (Fig. 2). In addi-
tion to the many F-box-containing proteins, the diversity of
Cdc53 homologs may provide combinatorial possibilities
for recognizing specific substrates. Another possibility is
that Skp1 and F-box proteins direct Cdks to their site of
action. Skp1 might couple Cdks to the CBF3–kinetochore
complex, to the site where Sic1 is degraded, or to the site
where cyclin A–Cdk2 directs DNA replication. According
to this model, Skp1 would promote phosphorylation, the
subsequent binding of Cdc53 complexes or their homologs,
and ultimately destruction.
The cullin family
The identification of a CDC53 homologue, cul-1, in a screen
for genes inhibiting hyperplasia in Caenorhabditis elegans is a
sign of the general importance of these genes in cell-cycle
control [20]. Kipreos et al. [20] found that cul-1 (also called
lin-19) is required for cells to exit the cell cycle, and that in
its absence cell division occurs inappropriately. Although
cell fate, differentiation and quiescence were apparently
not affected in a variety of lineages, cul1 mutants produced
abnormally small cells and excessive cell divisions.
Cloning of cul1 revealed the similarity of its product to
Cdc53 [20]. Database searching with the cul1 sequence
revealed a family of at least six human, five nematode and
three yeast genes, the products of which are now termed
cullins. Furthermore, mutation in a gene homologous to
CDC4 also caused hyperplasia in C. elegans. Together,
these results suggest that the Cdc34/Cdc4/Cdc53 pathway
is highly conserved, but may integrate a variety of signals.
These include nutritional signals in yeast, growth factors
like TGF-b, and possibly extracellular signals such as cell-
cell contact, cell attachment or contact inhibition.
The cul1 results suggest that genes for components of the
Cdc34 pathway could be tumor suppressor genes or onco-
genes. While no ubiquitinating enzyme is known to be an
oncogene product,  the gene for a ubiquitin-deconjugating
enzyme, DOA4, is homologous to an oncogene, tre-2 [3].
Mutations that stabilize cyclins — either directly or by
inactivating Cdk inhibitors or perturbing the ubiquitina-
tion machinery — may be of general importance in tumor
progression. It may be profitable to search for mutations
among genes in these pathways in human tumors or to
examine how biochemical regulators of ubiquitination
might be used therapeutically to block tumor growth.
References 
1. Kalderon D: Protein degradation: de-ubiquitinate to decide your
fate. Curr Biol 1996, 6:662–665.
2. Willems AR, Lanker S, Patton EE, Craig KL, Nason TF, Mathias N,
Kobayashi R, Wittenberg C, Tyers M: Cdc53 targets phosphorylated
G1 cyclins for degradation by the ubiquitin proteolytic pathway.
Cell 1996, 86:453–463.
3. Deshaies RJ: The self-destructive personality of a cell cycle in
transition. Curr Opin Cell Biol 1995, 6:781–789.
4. King RW, Peters JM, Tugendreich S, Rolfe M, Hieter P, W KM: A 20S
complex containing CDC27 and CDC16 catalyzes the mitosis-
specific conjugation of ubiquitin to cyclin B. Cell 1995,
81:279–288.
5. Sudakin V, Ganoth D, Dahan A, Heller H, Hershko J, Luca FC,
Ruderman JV, Herchko A: The cyclosome, a large complex
containing cyclin-selective ubiquitin ligase activity, targets cyclins
for destruction at the end of mitosis. Mol Biol Cell 1995,
6:185–197.
6. Glotzer M, Murray AW, Kirschner MW: Cyclin is degraded by the
ubiquitin pathway. Nature 1991, 349:132–138.
7. Yu H, King RW, Peters JM, Kirschner MW: Identification of a novel
ubiquitin-conjugating enzyme involved in mitotic cyclin
degradation. Curr Biol 1996, 6:455–466.
8. Salama SR, Hendricks KB, Thorner J: G1 cyclin degradation: the
PEST motif of yeast CLN2 is necessary, but not sufficient for rapid
protein turnover. Mol Cell Biol 1994, 14:7953–7966.
9. Lanker S, Valdivieso MH, Wittenberg C: Rapid degradation of the
G1 cyclin Cln2 is induced by CDK-dependent phosphorylation.
Science 1996, 271:1597–1601.
10. Goebl M, Yochem J, Jentsch S, McGrath JP, Varshavsky A, Byers B:
The yeast cell cycle gene cdc34 encodes a ubiquitin-conjugating
enzyme. Science 1988, 241:1331–1334.
11. Schwob E, Boehm T, Mendenhall MD, Nasmyth K: The B-type cyclin
inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae.
Cell 1994, 79:233–244.
12. Deshaies RJ, Chau V, Kirschner M: Ubiquitination of the G1 cyclin
Cln2p by a Cdc34-dependent pathway. EMBO J 1995,
14:303–312.
13. Barral Y, Jentsch S, Mann C: G1 cyclin turnover and nutrient uptake
are controlled by a common pathway in yeast. Genes Dev 1995,
9:399–409.
14. Kornitzer D, Raboy B, Kulka RG, Fink GR: Regulated degradation of
the transcription factor Gcn4. EMBO J 1994, 13:6021–6030.
15. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G,
Chau V, Yew PR, Draetta GF, Rolfe M. Role of the ubiquitin-
proteasome pathway in regulating abudance of the cyclin-
dependent kinase inhibitor p27. Science 1995, 269:682–685.
16. Zhang H, Koayashi R, Galaktionov K, Beach D: p19SKP1 and p45SKP2
are essential elements of the cyclin A-CDK2 S phase kinase. Cell
1995, 82:915–925.
17. Bai C, Sen P, Hoffman K, Ma L, Goebl M, Harper JW, Elledge SJ:
SKP1 connects cell cycle regulators to the ubiquitin proteolysis
machinery through a novel motif, the F-box. Cell 1996,
86:263–274.
18. Connelly C, Hieter P: Budding yeast SKP1 encodes an
evolutionarily conserved kinetochore protein required for cell
cycle progression. Cell 1996, 86:275–285.
19. Stemmann O, Lechner J: The Saccharomyces cerevisiae
kinetochore contains a cyclin-Cdk complexing homologue, as
identified by in vitro reconstitution. EMBO J 1996, 15:3611–3620.
20. Kipreos ET, Lander LE, Wing JP, He WW, Hedgecock EM: cul-1 is
required for cell cycle exit in C. elegans and identifies a novel
gene family. Cell 1996, 81:829–839.
1212 Current Biology 1996, Vol 6 No 10
